From Risk Stratification to Surveillance Decisions: Interpreting aMAP in Steatotic Liver Disease
Liver International · 2026-12 · 46 (12)
DOI: 10.1111/liv.70982 ↗Kurz gefasst
Leserbrief in der Zeitschrift Liver International, online erschienen am 13.11.2026. Verfasst von Shibing Hou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Acupuncture, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Med…. Die Arbeit nennt 4 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Acupuncture, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
- The First Clinical Medical School of Guangdong Pharmaceutical University, Guangzhou, China.
ORCID-Profile: Weiqu Yuan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hou, S., & Yuan, W. (2026). From Risk Stratification to Surveillance Decisions: Interpreting aMAP in Steatotic Liver Disease. Liver International, 46(12). https://doi.org/10.1111/liv.70982
Vancouver
Hou S, Yuan W. From Risk Stratification to Surveillance Decisions: Interpreting aMAP in Steatotic Liver Disease. Liver International. 2026;46(12). doi:10.1111/liv.70982
BibTeX
@article{Hou2026,
author = {Hou, Shibing and Yuan, Weiqu},
title = {From Risk Stratification to Surveillance Decisions: Interpreting aMAP in Steatotic Liver Disease},
journal = {Liver International},
year = {2026},
volume = {46},
number = {12},
doi = {10.1111/liv.70982}
}
EUVIMED